Could be game over for KVD900 | BCRX Message Board Posts


BioCryst Pharmaceuticals Inc.

  BCRX website

BCRX   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  12753 of 12775  at  7/12/2021 11:42:48 AM  by

moegrabbedmythumb

The following message was updated on 7/12/2021 11:45:24 AM.

Could be game over for KVD900

  KalVista's KVD900 is for administration only AFTER an attack occurs. With oral orladeyo (BCRX) taking over the oral prophylactic market there may be little to no need for KVD900 in the future.  Perhaps it can be a backup for those few attacks that make it through Orladeyo treatment (<5%?) KVD824 (HAE prophylactic drug) has not even begun phase 2 trials yet. GAME OVER!!  


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 1  
   Views: 0 [19]
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board


Financial Market Data provided by
.
Loading...